References
- Goonetilleke A, Modarres-Sadeghi H, Guiloff RJ. Accuracy, reproducibility, and variability of hand-held dynamometry in motor neuron disease. J. Neurol. Neurosurg. Psychiatry 57(3), 326–332 (1994).
- McDonald CM, Henricson EK, Han JJ et al. The 6-min walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 41(4), 500–510 (2010).
- Scotton C, Passarelli C, Neri M, Ferlini A. Biomarkers in rare neuromuscular diseases. Exp. Cell Res. 325(1), 44–49 (2014).
- Sanchez B, Rutkove SB. Present uses future applications, and technical underpinnings of electrical impedance myography. Curr. Neurol. Neurosci. Rep. 17(11), 86 (2017).
- Rutkove SB, Caress JB, Cartwright MS et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph. Lateral Scler. 13, 439–445 (2012).
- Rutkove SB, Kapur K, Zaidman CM et al. Electrical impedance myography for assessment of Duchenne muscular dystrophy. Ann. Neurol. 81(5), 622–632 (2017).
- Rutkove SB, Gregas MC, Darras BT. Electrical impedance myography in spinal muscular atrophy: a longitudinal study. Muscle Nerve 45(5), 642–647 (2012).
- Kortman HG, Wilder SC, Geisbush TR, Narayanaswami P, Rutkove SB. Age- and gender-associated differences in electrical impedance values of skeletal muscle. Physiol. Meas. 34(12), 1611–1622 (2013).
- Aaron R, Esper GJ, Shiffman CA, Bradonjic K, Lee KS, Rutkove SB. Effects of age on muscle as measured by electrical impedance myography. Physiol. Meas. 27(10), 953–959 (2006).
- Carlson CG, Bruemmer K, Sesti J et al. Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse. Muscle Nerve 43(5), 694–699 (2011).
- Morrison BM, Lachey JL, Warsing LC et al. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 217(2), 258–268 (2009).
- Sanchez B, Li J, Yim S, Pacheck A, Widrick JJ, Rutkove SB. Evaluation of electrical impedance as a biomarker of myostatin inhibition in wild type and muscular dystrophy mice. PLoS ONE 10(10), e0140521 (2015).
- Cadena SM, Tomkinson KN, Monnell TE et al. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. J. Appl. Physiol. 109(3), 635–642 (2010).
- Tinklenberg J, Meng H, Yang L et al. Treatment with ActRIIB-mFc produces myofiber growth and improves lifespan in the Acta1 H40Y murine model of nemaline myopathy. Am. J. Pathol. 186(6), 1568–1581 (2016).
- Lawlor MW, Read BP, Edelstein R et al. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. Am. J. Pathol. 178(2), 784–793 (2011).
- Lawlor MW, Viola MG, Meng H et al. Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice. Am. J. Pathol. 184(6), 1831–1842 (2014).
- Koncarevic A, Cornwall-Brady M, Pullen A et al. A soluble activin receptor type IIB prevents the effects of androgen deprivation on body composition and bone health. Endocrinology 151(9), 4289–4300 (2010).
- Koncarevic A, Kajimura S, Cornwall-Brady M et al. A novel therapeutic approach to treating obesity through modulation of TGFβ signaling. Endocrinology 153(7), 3133–3146 (2012).
- Li J, Staats WL, Spieker A, Sung M, Rutkove SB. A technique for performing electrical impedance myography in the mouse hind limb: data in normal and ALS SOD1 G93A animals. PLoS ONE 7(9), e45004 (2012).
- Grimnes S, Martinsen OG. Bioimpedance and Bioelectricity Basics (3rd Edition). Academic Press, MA, USA (2014).
- Li J, Pacheck A, Sanchez B, Rutkove SB. Single and modeled multifrequency electrical impedance myography parameters and their relationship to force production in the ALS SOD1G93A mouse. Amyotroph. Lateral Scler. Frontotemporal Degener. 8421, 1–7 (2016).
- Arnold WD, McGovern VL, Sanchez B et al. The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy. Neurobiol. Dis. 87, 116–123 (2016).